Press "Enter" to skip to content

New patent for Biogen Idec drug TECFIDERA

0
Copyright © DrugPatentWatch. Originally published at New patent for Biogen Idec drug TECFIDERA

Annual Drug Patent Expirations for TECFIDERA
Annual Drug Patent Expirations for TECFIDERA

Tecfidera is a drug marketed by Biogen Idec Inc and is included in one NDA. It is available from two suppliers. There is one patent protecting this drug and one Paragraph IV challenge.

Drug patent litigation for TECFIDERA.

This drug has sixteen patent family members in twelve countries.

The generic ingredient in TECFIDERA is dimethyl fumarate. Two suppliers are listed for this compound. Additional details are available on the dimethyl fumarate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Biogen Idec drug TECFIDERA
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    DrugPatentWatch - Make Better Decisions